Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA))

door E. S. Kropacheva, E. N. Krivosheeva, E. P. Panchenko
Gepubliceerd in 2021-07-01

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention

door E. N. Krivosheeva, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko
Gepubliceerd in 2021-08-01

SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)

door E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva
Gepubliceerd in 2017-05-01

CLINICAL ANALYSIS OF A PATIENT WITH ANTIPHOSPHOLIPID SYNDROME AND SUB-MASSIVE PULMONARY EMBOLISM

door E. N. Krivosheeva, A. L. Komarov, R. M. Shakhnovich, I. S. Fedotchenkov, E. Р. Panchenko
Gepubliceerd in 2018-05-01

Long-term outcomes of coronary artery bypass graft surgery in patients with widespread atherosclerotic lesions of the coronary and peripheral vascular basins (based on the REGATA l...

door E. N. Krivosheeva, A. L. Komarov, D. M. Galyautdinov, E. E. Vlasova, R. S. Akchurin, E. P. Panchenko
Gepubliceerd in 2022-01-01